Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1783881
Max Phase: Preclinical
Molecular Formula: C15H19F3N2O2
Molecular Weight: 202.30
Molecule Type: Small molecule
Associated Items:
ID: ALA1783881
Max Phase: Preclinical
Molecular Formula: C15H19F3N2O2
Molecular Weight: 202.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)C(F)(F)F.c1cncc(CC2CC3CCN2CC3)c1
Standard InChI: InChI=1S/C13H18N2.C2HF3O2/c1-2-12(10-14-5-1)9-13-8-11-3-6-15(13)7-4-11;3-2(4,5)1(6)7/h1-2,5,10-11,13H,3-4,6-9H2;(H,6,7)
Standard InChI Key: WAEBNAPRWKRNPD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 202.30 | Molecular Weight (Monoisotopic): 202.1470 | AlogP: 2.11 | #Rotatable Bonds: 2 |
Polar Surface Area: 16.13 | Molecular Species: BASE | HBA: 2 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.04 | CX LogP: 1.71 | CX LogD: 0.06 |
Aromatic Rings: 1 | Heavy Atoms: 15 | QED Weighted: 0.73 | Np Likeness Score: -0.35 |
1. Breining SR, Bencherif M, Grady SR, Whiteaker P, Marks MJ, Wageman CR, Lester HA, Yohannes D.. (2009) Evaluation of structurally diverse neuronal nicotinic receptor ligands for selectivity at the alpha6( *) subtype., 19 (15): [PMID:19560354] [10.1016/j.bmcl.2009.05.085] |
Source(1):